New glucose-sensitive insulin NNC2215 could transform diabetes care by lowering hypoglycemia risk

NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, reducing hypoglycemia in diabetes care.

Diversity statements should not be required for federal STEMM grant funding

Federally funded research in science, technology, engineering, mathematics, and medicine (STEMM) is a crown jewel of American higher education that confers enormous benefits upon the

August 5, 2024

Novartis sues Takeda after former employee allegedly shared trade secrets

Novartis is suing Takeda in a Massachusetts state court to determine whether a former employee of its Egyptian subsidiary has been distributing trade secrets mined

October 27, 2023

Penumbra touts benefits of vacuum thrombectomy for PE in late-breaking data

Dive Brief: Penumbra shared interim results supporting the safety and effectiveness of its computer-aided vacuum thrombectomy system for treating pulmonary embolism. The single-arm study showed

November 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.